MADISON SQUARE GARDEN SPORTS (MSGS) Stock Fundamental Analysis

NYSE:MSGS • US55825T1034

313.97 USD
-0.12 (-0.04%)
At close: Feb 24, 2026
313.97 USD
0 (0%)
After Hours: 2/24/2026, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, MSGS scores 3 out of 10 in our fundamental rating. MSGS was compared to 80 industry peers in the Entertainment industry. Both the profitability and financial health of MSGS have multiple concerns. While showing a medium growth rate, MSGS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year MSGS has reported negative net income.
  • In the past year MSGS had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: MSGS reported negative net income in multiple years.
  • MSGS had a positive operating cash flow in 4 of the past 5 years.
MSGS Yearly Net Income VS EBIT VS OCF VS FCFMSGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M -300M

1.2 Ratios

  • With a Return On Assets value of -1.56%, MSGS perfoms like the industry average, outperforming 53.75% of the companies in the same industry.
Industry RankSector Rank
ROA -1.56%
ROE N/A
ROIC N/A
ROA(3y)2.11%
ROA(5y)1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MSGS Yearly ROA, ROE, ROICMSGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

1.3 Margins

  • In the last couple of years the Operating Margin of MSGS has declined.
  • MSGS has a Gross Margin of 32.94%. This is comparable to the rest of the industry: MSGS outperforms 43.75% of its industry peers.
  • MSGS's Gross Margin has declined in the last couple of years.
  • MSGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.94%
OM growth 3Y-48.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.62%
GM growth 5Y-3.48%
MSGS Yearly Profit, Operating, Gross MarginsMSGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

3

2. Health

2.1 Basic Checks

  • MSGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MSGS has been increased compared to 1 year ago.
  • MSGS has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MSGS has an improved debt to assets ratio.
MSGS Yearly Shares OutstandingMSGS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
MSGS Yearly Total Debt VS Total AssetsMSGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • MSGS has an Altman-Z score of 2.73. This is not the best score and indicates that MSGS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MSGS has a Altman-Z score of 2.73. This is in the better half of the industry: MSGS outperforms 76.25% of its industry peers.
  • MSGS has a debt to FCF ratio of 9.97. This is a negative value and a sign of low solvency as MSGS would need 9.97 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 9.97, MSGS is doing good in the industry, outperforming 63.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.97
Altman-Z 2.73
ROIC/WACCN/A
WACC10.09%
MSGS Yearly LT Debt VS Equity VS FCFMSGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 0.39 indicates that MSGS may have some problems paying its short term obligations.
  • With a Current ratio value of 0.39, MSGS is not doing good in the industry: 83.75% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.39 indicates that MSGS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.39, MSGS is doing worse than 83.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
MSGS Yearly Current Assets VS Current LiabilitesMSGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • MSGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -129.11%.
  • Looking at the last year, MSGS shows a small growth in Revenue. The Revenue has grown by 1.18% in the last year.
  • The Revenue has been growing by 11.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-129.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%580%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y8.16%
Revenue growth 5Y11.49%
Sales Q2Q%12.76%

3.2 Future

  • MSGS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.89% yearly.
  • Based on estimates for the next years, MSGS will show a small growth in Revenue. The Revenue will grow by 3.47% on average per year.
EPS Next Y82.04%
EPS Next 2Y32.53%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year0.99%
Revenue Next 2Y2.78%
Revenue Next 3Y3.47%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MSGS Yearly Revenue VS EstimatesMSGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
MSGS Yearly EPS VS EstimatesMSGS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 -4 6 -6

2

4. Valuation

4.1 Price/Earnings Ratio

  • MSGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year MSGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MSGS Price Earnings VS Forward Price EarningsMSGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K

4.2 Price Multiples

  • MSGS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MSGS is cheaper than 61.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 259.01
EV/EBITDA N/A
MSGS Per share dataMSGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MSGS's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.53%
EPS Next 3Y24.89%

0

5. Dividend

5.1 Amount

  • No dividends for MSGS!.
Industry RankSector Rank
Dividend Yield 0%

MADISON SQUARE GARDEN SPORTS

NYSE:MSGS (2/24/2026, 8:04:00 PM)

After market: 313.97 0 (0%)

313.97

-0.12 (-0.04%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-05
Earnings (Next)05-04
Inst Owners81.79%
Inst Owner ChangeN/A
Ins Owners2.36%
Ins Owner Change6.03%
Market Cap7.56B
Revenue(TTM)1.04B
Net Income(TTM)-23.70M
Analysts78.57
Price Target269.75 (-14.08%)
Short Float %5.09%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-2.25%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.25%
Min EPS beat(2)39.44%
Max EPS beat(2)57.05%
EPS beat(4)2
Avg EPS beat(4)-32.18%
Min EPS beat(4)-141.27%
Max EPS beat(4)57.05%
EPS beat(8)5
Avg EPS beat(8)10.78%
EPS beat(12)7
Avg EPS beat(12)-4.95%
EPS beat(16)9
Avg EPS beat(16)16.9%
Revenue beat(2)1
Avg Revenue beat(2)11.52%
Min Revenue beat(2)-6.35%
Max Revenue beat(2)29.38%
Revenue beat(4)1
Avg Revenue beat(4)4.86%
Min Revenue beat(4)-6.35%
Max Revenue beat(4)29.38%
Revenue beat(8)4
Avg Revenue beat(8)8.83%
Revenue beat(12)8
Avg Revenue beat(12)12.75%
Revenue beat(16)10
Avg Revenue beat(16)14.87%
PT rev (1m)6.08%
PT rev (3m)5.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)103.02%
EPS NY rev (1m)0%
EPS NY rev (3m)76.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.37
P/FCF 259.01
P/OCF 230.33
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)1.21
FCFY0.39%
OCF(TTM)1.36
OCFY0.43%
SpS42.6
BVpS-12.22
TBVpS-25.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.56%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.94%
FCFM 2.85%
ROA(3y)2.11%
ROA(5y)1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.02%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-48.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.62%
GM growth 5Y-3.48%
F-Score3
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 9.97
Debt/EBITDA N/A
Cap/Depr 111.89%
Cap/Sales 0.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z 2.73
F-Score3
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)60.4%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-129.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%580%
EPS Next Y82.04%
EPS Next 2Y32.53%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)1.18%
Revenue growth 3Y8.16%
Revenue growth 5Y11.49%
Sales Q2Q%12.76%
Revenue Next Year0.99%
Revenue Next 2Y2.78%
Revenue Next 3Y3.47%
Revenue Next 5YN/A
EBIT growth 1Y-102.85%
EBIT growth 3Y-44.39%
EBIT growth 5YN/A
EBIT Next Year-52.77%
EBIT Next 3Y-8.47%
EBIT Next 5YN/A
FCF growth 1Y-68.56%
FCF growth 3Y-20.81%
FCF growth 5YN/A
OCF growth 1Y-66.21%
OCF growth 3Y-19.88%
OCF growth 5Y91.04%

MADISON SQUARE GARDEN SPORTS / MSGS FAQ

What is the fundamental rating for MSGS stock?

ChartMill assigns a fundamental rating of 3 / 10 to MSGS.


Can you provide the valuation status for MADISON SQUARE GARDEN SPORTS?

ChartMill assigns a valuation rating of 2 / 10 to MADISON SQUARE GARDEN SPORTS (MSGS). This can be considered as Overvalued.


What is the profitability of MSGS stock?

MADISON SQUARE GARDEN SPORTS (MSGS) has a profitability rating of 2 / 10.


How financially healthy is MADISON SQUARE GARDEN SPORTS?

The financial health rating of MADISON SQUARE GARDEN SPORTS (MSGS) is 3 / 10.